278 related articles for article (PubMed ID: 14602858)
1. Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.
Duet M; Sauvaget E; Pételle B; Rizzo N; Guichard JP; Wassef M; Le Cloirec J; Herman P; Tran Ba Huy P
J Nucl Med; 2003 Nov; 44(11):1767-74. PubMed ID: 14602858
[TBL] [Abstract][Full Text] [Related]
2. [Scintigraphy by l'Octreoscan in the management of head and neck paragangliomas].
Duet M; Sauvaget E; Guichard JP; Petelle B; Ledjedel S; Herman P; Tran Ba Huy P
Ann Otolaryngol Chir Cervicofac; 2002 Dec; 119(6):315-21. PubMed ID: 12527839
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas.
Schmidt M; Fischer E; Dietlein M; Michel O; Weber K; Moka D; Stennert E; Schicha H
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1571-80. PubMed ID: 12458390
[TBL] [Abstract][Full Text] [Related]
4. 111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.
Koopmans KP; Jager PL; Kema IP; Kerstens MN; Albers F; Dullaart RP
J Nucl Med; 2008 Aug; 49(8):1232-7. PubMed ID: 18632829
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A
Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839
[TBL] [Abstract][Full Text] [Related]
6. Are somatostatin analogs therapeutic alternatives in the management of head and neck paragangliomas?
Duet M; Guichard JP; Rizzo N; Boudiaf M; Herman P; Tran Ba Huy P
Laryngoscope; 2005 Aug; 115(8):1381-4. PubMed ID: 16094109
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and follow-up of head and neck paragangliomas. Contributions of nuclear medicine].
Tamayo Alonso P; Ruano Pérez R; Muñoz Herrera A
Acta Otorrinolaringol Esp; 2009 Feb; 60 Suppl 1():68-75. PubMed ID: 19245777
[TBL] [Abstract][Full Text] [Related]
8. Octreotide scintigraphy for the detection of paragangliomas.
Kwekkeboom DJ; van Urk H; Pauw BK; Lamberts SW; Kooij PP; Hoogma RP; Krenning EP
J Nucl Med; 1993 Jun; 34(6):873-8. PubMed ID: 8389841
[TBL] [Abstract][Full Text] [Related]
9. 111Indium pentetreotide imaging in the evaluation of head and neck tumors.
Myssiorek D; Tronco G
Laryngoscope; 2005 Oct; 115(10):1707-16. PubMed ID: 16222183
[TBL] [Abstract][Full Text] [Related]
10. 111Indium pentetreotide scan detection of familial paragangliomas.
Myssiorek D; Palestro CJ
Laryngoscope; 1998 Feb; 108(2):228-31. PubMed ID: 9473073
[TBL] [Abstract][Full Text] [Related]
11. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative gamma probe detection of head and neck paragangliomas with 111In-pentetreotide: a pilot study.
Filippi L; Valentini FB; Gossetti B; Gossetti F; De Vincentis G; Scopinaro F; Massa R
Tumori; 2005; 91(2):173-6. PubMed ID: 15948547
[TBL] [Abstract][Full Text] [Related]
13. Value of 123I-MIBG Scintigraphy in Paraganglioma.
Milardovic R; Corssmit EP; Stokkel M
Neuroendocrinology; 2010; 91(1):94-100. PubMed ID: 19786729
[TBL] [Abstract][Full Text] [Related]
14. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine tumors and somatostatin: imaging techniques.
de Herder WW; Kwekkeboom DJ; Valkema R; Feelders RA; van Aken MO; Lamberts SW; van der Lely AJ; Krenning EP
J Endocrinol Invest; 2005; 28(11 Suppl International):132-6. PubMed ID: 16625862
[TBL] [Abstract][Full Text] [Related]
17. Bone metastases from head and neck paragangliomas: uncommon MR findings in an uncommon condition--report of three cases.
Duet M; Herman P; Wassef M; Tran BH; Laredo JD
J Magn Reson Imaging; 2006 Aug; 24(2):428-33. PubMed ID: 16786569
[TBL] [Abstract][Full Text] [Related]
18. Octreotide scintigraphy for the detection of paragangliomas.
Telischi FF; Bustillo A; Whiteman ML; Serafini AN; Reisberg MJ; Gomez-Marin O; Civantos FJ; Balkany TJ
Otolaryngol Head Neck Surg; 2000 Mar; 122(3):358-62. PubMed ID: 10699810
[TBL] [Abstract][Full Text] [Related]
19. Octreotide scintigraphy in the head and neck.
Bustillo A; Telischi F; Weed D; Civantos F; Angeli S; Serafini A; Whiteman M
Laryngoscope; 2004 Mar; 114(3):434-40. PubMed ID: 15091215
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
